Wayne J Morgan
Overview
Explore the profile of Wayne J Morgan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
5673
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szczesniak R, Andrinopoulou E, Li H, Jain R, Mayer-Hamblett N, Ostrenga J, et al.
J Cyst Fibros
. 2025 Feb;
PMID: 39929763
Background: Increased variability in forced expiratory volume in 1 s of % predicted (FEVpp) has been associated with accelerated lung function decline in individuals with cystic fibrosis (CF). Lung function...
2.
Schechter M, Ostrenga J, Cromwell E, Ren C, Fink A, Sanders D, et al.
Pediatr Pulmonol
. 2024 Jul;
59(12):3212-3220.
PMID: 38995116
Background: The benefit of antibiotic treatment of acute drops in FEV percent predicted (FEVpp) has been clearly established, but data from the early 2000s showed inconsistent treatment. Further, there is...
3.
Todd J, Morgan W, Szczesniak R, Ostrenga J, OConnell O, Cromwell E, et al.
Ann Am Thorac Soc
. 2024 Jun;
21(10):1416-1420.
PMID: 38889346
Declines in percent predicted forced expiratory volume in 1 second (ppFEV) are an important marker of clinical progression of cystic fibrosis (CF). We examined ppFEV variability in relation to a...
4.
Rosenfeld M, Cromwell E, Schechter M, Ren C, Flume P, Szczesniak R, et al.
J Cyst Fibros
. 2024 Mar;
23(3):443-449.
PMID: 38556415
Rationale: The American Thoracic Society recommended switching to race-neutral spirometry reference equations, as race is a social construct and to avoid normalizing disparities in lung function due to structural racism....
5.
Tepper R, Morgan W, Taussig L
Am J Respir Crit Care Med
. 2024 Feb;
209(8):1040-1041.
PMID: 38301264
No abstract available.
6.
Zhai J, Voraphani N, Imboden M, Keidel D, Liu C, Stern D, et al.
J Allergy Clin Immunol
. 2024 Jan;
153(6):1692-1703.
PMID: 38253260
Background: Airflow limitation is a hallmark of chronic obstructive pulmonary disease, which can develop through different lung function trajectories across the life span. There is a need for longitudinal studies...
7.
Simon R, Quittell L, Morgan W
J Cyst Fibros
. 2023 Dec;
23(1):65-67.
PMID: 38151411
No abstract available.
8.
Sanders D, Bartz T, Zemanick E, Hoppe J, Stukovsky K, Cogen J, et al.
Ann Am Thorac Soc
. 2023 Sep;
20(12):1769-1776.
PMID: 37683122
Despite the high prevalence and clear morbidity of cystic fibrosis (CF) pulmonary exacerbations (PEx), there have been no published clinical trials of outpatient exacerbation management. To assess the feasibility of...
9.
DeBoer E, Morgan W, Quiros-Alcala L, Rosenfeld M, Stout J, Davis S, et al.
Pediatrics
. 2023 Sep;
152(Suppl 2).
PMID: 37656029
Lifelong respiratory health is rooted in the structural and functional development of the respiratory system in early life. Exposures and interventions antenatally through childhood can influence lung development into young...
10.
Voraphani N, Stern D, Ledford J, Spangenberg A, Zhai J, Wright A, et al.
Am J Respir Crit Care Med
. 2023 Jul;
208(7):758-769.
PMID: 37523710
Club cell secretory protein (CC16) is an antiinflammatory protein highly expressed in the airways. CC16 deficiency has been associated with lung function deficits, but its role in asthma has not...